Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.37% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.41% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Repay Holdings
RPAY
$303M
| $1.02M | ﹤0.01% |
135,000
+5,200
| +4% | +$43.3K |
|
2277
ALX Oncology
ALXO
$271M
| $1.02M | ﹤0.01% |
212,500
+29,700
| +16% | +$161K |
|
2278
Eltek
ELTK
$57.9M
| $1.02M | ﹤0.01% |
107,723
+47,100
| +78% | +$404K |
|
|
NOAH
2279
Noah Holdings
NOAH
$592M
| $1.02M | ﹤0.01% |
81,800
+24,800
| +44% | +$339K |
|
2280
Compugen
CGEN
$228M
| $1.02M | ﹤0.01% |
1,094,300
+55,900
| +5% | +$61.5K |
|
2281
iShares Global Infrastructure ETF
IGF
$10.7B
| $1.02M | ﹤0.01% |
23,500
-2,000
| -8% | -$91.9K |
|
2282
Lightpath Technologies
LPTH
$953M
| $1.01M | ﹤0.01% |
699,400
-37,800
| -5% | -$63.2K |
|
|
ZIMV
2283
DELISTED
ZimVie
ZIMV
| $1.01M | ﹤0.01% |
107,800
+29,000
| +37% | +$335K |
|
|
CTV
2284
DELISTED
Innovid Corp.
CTV
| $1.01M | ﹤0.01% |
791,912
-46,600
| -6% | -$54.5K |
|
|
MBCN
2285
DELISTED
Middlefield Banc Corp
MBCN
| $1.01M | ﹤0.01% |
39,812
+100
| +0.3% | +$2.75K |
|
|
SRTA
2286
Strata Critical Medical Inc
SRTA
$522M
| $1.01M | ﹤0.01% |
390,199
+182,699
| +88% | +$642K |
|
|
LITS
2287
Lite Strategy Inc
LITS
$30.2M
| $1.01M | ﹤0.01% |
144,246
-500
| -0.3% | -$3.28K |
|
2288
Dimensional US High Profitability ETF
DUHP
$12.8B
| $1.01M | ﹤0.01% |
39,300
+10,100
| +35% | +$270K |
|
2289
Shinhan Financial Group
SHG
$35.4B
| $1.01M | ﹤0.01% |
+38,100
| New | +$1.02M |
|
2290
eHealth
EHTH
$39.1M
| $1.01M | ﹤0.01% |
136,128
-86,600
| -39% | -$680K |
|
2291
Onto Innovation
ONTO
$20.3B
| $1M | ﹤0.01% |
+7,874
| New | +$936K |
|
|
TRIB
2292
Trinity Biotech
TRIB
$7.88M
| $1M | ﹤0.01% |
9,088
-64
| -0.7% | -$7.87K |
|
|
MITT
2293
TPG Mortgage Investment Trust
MITT
$215M
| $1M | ﹤0.01% |
180,100
+29,500
| +20% | +$187K |
|
2294
Vanguard Russell 1000 Value ETF
VONV
$22B
| $1M | ﹤0.01% |
15,000
+9,400
| +168% | +$654K |
|
2295
Viridian Therapeutics
VRDN
$2.5B
| $1M | ﹤0.01% |
65,200
-10,800
| -14% | -$206K |
|
|
CMRX
2296
DELISTED
Chimerix, Inc.
CMRX
| $999K | ﹤0.01% |
1,041,109
-1,030,200
| -50% | -$1.12M |
|
|
HRT
2297
DELISTED
HireRight Holdings Corporation
HRT
| $999K | ﹤0.01% |
105,013
-131,887
| -56% | -$1.36M |
|
2298
CVRx
CVRX
$82.1M
| $997K | ﹤0.01% |
65,700
+3,300
| +5% | +$54.3K |
|
2299
GXO Logistics
GXO
$5.59B
| $997K | ﹤0.01% |
17,000
-48,000
| -74% | -$3M |
|
2300
Kornit Digital
KRNT
$775M
| $997K | ﹤0.01% |
52,700
-26,200
| -33% | -$646K |
|
Similar funds
Jim Simons's Q3 2023 Portfolio in Review
As of Q3 2023, Jim Simons held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.34B in Q3 2023, closing 713 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in D.R. Horton worth $125M.
- Jim Simons's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Jim Simons added most to Netflix in Q3 2023, an estimated $385M increase.
- Jim Simons's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Jim Simons fully exited Chevron in Q3 2023, selling an estimated $185M.
- Jim Simons's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Jim Simons opened 464 new positions and closed 713 in Q3 2023.
- Jim Simons's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.